Drug repositioning based on network-specific core genes identifies potential drugs for the treatment of autism spectrum disorder in children

Jeste, 2014, Disentangling the heterogeneity of autism spectrum disorder through genetic findings, Nat Rev Neurol, 10, 74, 10.1038/nrneurol.2013.278 Ecker, 2015, Neuroimaging in autism spectrum disorder: brain structure and function across the lifespan, Lancet Neurol, 14, 1121, 10.1016/S1474-4422(15)00050-2 Jon Baio E, Wiggins L, Christensen DL, Maenner MJ, Daniels J, Warren Z: Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014. Morbidity and Mortality Weekly Report (MMWR) 2018. Ji, 2015, An update on pharmacotherapy for autism spectrum disorder in children and adolescents, Curr Opin Psychiatr, 28, 91, 10.1097/YCO.0000000000000132 Mazzone, 2017, Drug treatments for core symptoms of autism spectrum disorder: unmet needs and future directions, J Pediatr Neurol, 15, 134, 10.1055/s-0037-1602823 Xue, 2018, Review of drug repositioning approaches and resources, Int J Biol Sci, 14, 1232, 10.7150/ijbs.24612 Pushpakom, 2019, Drug repurposing: progress, challenges and recommendations, Nat Rev Drug Discov, 18, 41, 10.1038/nrd.2018.168 Ashburn, 2004, Drug repositioning: identifying and developing new uses for existing drugs, Nat Rev Drug Discov, 3, 673, 10.1038/nrd1468 Hodos, 2016, In silico methods for drug repurposing and pharmacology, Wiley Interdip Rev Syst Biol Med, 8, 186, 10.1002/wsbm.1337 Lamb, 2007, The Connectivity Map: a new tool for biomedical research, Nat Rev Cancer, 7, 54, 10.1038/nrc2044 Koudijs, 2019, Transcriptome signature reversion as a method to reposition drugs against cancer for precision oncology, Cancer J, 25, 116, 10.1097/PPO.0000000000000370 Dudley, 2011, Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease, Sci Transl Med, 3, 10.1126/scitranslmed.3002648 So, 2017, Analysis of genome-wide association data highlights candidates for drug repositioning in psychiatry, Nat Neurosci, 20, 1342, 10.1038/nn.4618 Bourgeron, 2015, From the genetic architecture to synaptic plasticity in autism spectrum disorder, Nature Rev Neuroence, 16, 551, 10.1038/nrn3992 Noh, 2013, Network topologies and convergent aetiologies arising from deletions and duplications observed in individuals with autism, PLoS Genet, 9, e1003523, 10.1371/journal.pgen.1003523 Parikshak, 2016, Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism, Nature, 540, 423, 10.1038/nature20612 Barabási, 2011, Network medicine: a network-based approach to human disease, Nat Rev Genet, 12, 56, 10.1038/nrg2918 Park, 2017, Network mirroring for drug repositioning, BMC Med Inf Decis Making, 17, 55, 10.1186/s12911-017-0449-x Wright, 2017, Altered expression of histamine signaling genes in autism spectrum disorder, Transl Psychiat, 7, 10.1038/tp.2017.87 Liu, 2016, Disruption of an evolutionarily novel synaptic expression pattern in autism, PLoS Biol, 14, e1002558, 10.1371/journal.pbio.1002558 He, 2014, Conserved expression of lincRNA during human and macaque prefrontal cortex development and maturation, Palliative Med, 20, 1103 Li J, Shi M, Ma Z, Zhao S, Euskirchen G, Ziskin J, Urban A, Hallmayer J, Snyder M: Integrated systems analysis reveals a molecular network underlying autism spectrum disorders. Mol Syst Biol 2014. Anthony, M, Bolger, Marc, Lohse, Bjoern, Usadel: Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics (Oxford, England) 2014. Trapnell C, Pachter L, Salzberg SL: TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 2009. Anders, 2015, HTSeq—a Python framework to work with high-throughput sequencing data, Bioinformatics, 10.1093/bioinformatics/btu638 Love, 2014, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2, Genome Biol, 15, 10.1186/s13059-014-0550-8 Jeffrey T, Leek W, Evan, Johnson, Hilary S, Parker, Andrew: The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics (Oxford, England) 2012. Langfelder, 2008, WGCNA: an R package for weighted correlation network analysis, BMC Bioinf, 9, 10.1186/1471-2105-9-559 Robinson, 2010, edgeR: a Bioconductor package for differential expression analysis of digital gene expression data, Biogeoences, 26, 139 Abrahams, 2013, SFARI Gene 2.0: a community-driven knowledgebase for the autism spectrum disorders (ASDs), Mol Autism, 4, 36, 10.1186/2040-2392-4-36 Xu LM, Li JR, Huang Y, Zhao M, Tang X, Wei L. AutismKB: an evidence-based knowledgebase of autism genetics. Nucleic Acids Res 2012, 40(Database issue):D1016-D1022. Wishart, 2006, DrugBank: a comprehensive resource for in silico drug discovery and exploration, Nucl Acids Res, 34, D668, 10.1093/nar/gkj067 A GH, Christopher H, Gerome B. Drug Targetor: a web interface to investigate the human druggome for over 500 phenotypes. Bioinformatics 2019, 14(35):2515-2517. Subramanian, 2005, Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc Natl Acad Sci - PNAS, 102, 15545, 10.1073/pnas.0506580102 Subramanian, 2017, A next generation connectivity map: L1000 platform and the first 1,000,000 profiles, Cell, 171, 1437, 10.1016/j.cell.2017.10.049 Lample, 2016, Neural Architec Named Entity Recogn Qi P, Dozat T, Zhang Y, Manning CD. Universal Dependency Parsing from Scratch. 2019. Bello, 2018, Disease Ontology: improving and unifying disease annotations across species, Dis Model Mech, 11 Yoshinobu I, Noriyuki N, Tomoya Y, Atsushi O, Yasuo O, Tetsuro U, Hiroshi Y. Open TG-GATEs: a large-scale toxicogenomics database. Nucleic Acids Res 2015(D1):D921. Gusenleitner, 2014, Genomic models of short-term exposure accurately predict long-term chemical carcinogenicity and identify putative mechanisms of action, PLoS One, 9, e102579, 10.1371/journal.pone.0102579 Smyth GK, Ritchie M, Thorne N, Wettenhall J, Shi W. limma: Linear Models for Microarray Data. Bioinformatics & Computational Biology Solutions Using R & Bioconductor 2010. Yu, 2012, clusterProfiler: an R package for comparing biological themes among gene clusters, OMICS, 16, 284, 10.1089/omi.2011.0118 Vargas, 2018, Alzheimer's disease master regulators analysis: search for potential molecular targets and drug repositioning candidates, Alzheimers Res Ther, 10, 59, 10.1186/s13195-018-0394-7 Liang, 2007, Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain, Physiol Genomics, 28, 311, 10.1152/physiolgenomics.00208.2006 Boisgueheneuc, 2006, Functions of the left superior frontal gyrus in humans: a lesion study, Brain, 129, 3315, 10.1093/brain/awl244 Jackson, 2018, An emergent functional parcellation of the temporal cortex, Neuroimage, 170, 385, 10.1016/j.neuroimage.2017.04.024 Estes, 2015, Immune mediators in the brain and peripheral tissues in autism spectrum disorder, Nat Rev Neurosci, 16, 469, 10.1038/nrn3978 Jaehne, 2015, Effects of Npas4 deficiency on anxiety, depression-like, cognition and sociability behaviour, Behav Brain Res, 281, 276, 10.1016/j.bbr.2014.12.044 Hollis, 2017, Mitochondrial dysfunction in Autism Spectrum Disorder: clinical features and perspectives, Curr Opin Neurobiol, 45, 178, 10.1016/j.conb.2017.05.018 Giulivi, 2010, Mitochondrial dysfunction in autism, JAMA, J Am Med Assoc, 304, 2389, 10.1001/jama.2010.1706 Guevara-Campos, 2013, Autism spectrum disorders associated to a deficiency of the enzymes of the mitochondrial respiratory chain, Metab Brain Dis, 28, 605, 10.1007/s11011-013-9419-x Bharath SM. M. Post-Translational Oxidative Modifications of Mitochondrial Complex I (NADH: Ubiquinone Oxidoreductase): Implications for Pathogenesis and Therapeutics in Human Diseases. J Alzheimers Dis 2017:1-18. Chauhan A, Gu F, Essa MM, Wegiel J, Kaur K, Brown WT, Chauhan V: Brain region-specific deficit in mitochondrial electron transport chain complexes in children with autism. J Neurochem 2011, 117(2):209-220. Anitha, 2013, Downregulation of the expression of mitochondrial electron transport complex genes in autism brains, Brain Pathol, 23, 294, 10.1111/bpa.12002 Tripathi, Lokesh P, Prathipati, Philip, Mizuguchi, Kenji, Murakami, Yoichi: Network analysis and in silico prediction of protein-protein interactions with applications in drug discovery. Curr Opin Struc Biol 2017. Zhu, 2014, Evaluating Protein-protein Interaction (PPI) Networks for Diseases Pathway, Target Discovery, and Drug-design Using ‘In silico Pharmacology‘, Curr Protein Pept Sci, 15 Kotlyar, 2012, Network-based characterization of drug-regulated genes, drug targets, and toxicity, Methods, 57, 499, 10.1016/j.ymeth.2012.06.003 Domínguez-Iturza, 2019, The autism- and schizophrenia-associated protein CYFIP1 regulates bilateral brain connectivity and behaviour, Nat Commun, 10, 10.1038/s41467-019-11203-y Naaijen, 2017, Glutamatergic and GABAergic gene sets in attention-deficit/hyperactivity disorder: association to overlapping traits in ADHD and autism, Transl Psychiat, 7, 10.1038/tp.2016.273 Guan, 2019, Commonality in dysregulated expression of gene sets in cortical brains of individuals with autism, schizophrenia, and bipolar disorder, Transl Psychiat, 9, 10.1038/s41398-019-0488-4 Penn R. Intrathecal baclofen for severe spinal spasticity Lancet 326(8447) 1985 125–127. Mahdavinasab SM, Saghazadeh A, Motamed-Gorji N, Vaseghi S, Mohammadi MR, Alichani R, Akhondzadeh S: Baclofen as an adjuvant therapy for autism: a randomized, double-blind, placebo-controlled trial. Eur Child Adoles Psy 2019. Wang, 2010, Sulpiride augmentation for schizophrenia, Schizophrenia Bull, 36, 229, 10.1093/schbul/sbp163 Scott, 1988, Use of sulpiride in a case of atypical autism, J Autism dev disord, 18, 144, 10.1007/BF02211825 Jory, 2016, Abnormal fatty acids in Canadian children with autism, Nutrition, 32, 474, 10.1016/j.nut.2015.10.019 Ohara, 2007, The n-3 polyunsaturated fatty acid/dopamine hypothesis of schizophrenia, Prog Neuropsychopharmacol Biol Psychiatry, 31, 469, 10.1016/j.pnpbp.2006.11.013 Betancur, 2009, The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders, Trends Neurosci, 32, 402, 10.1016/j.tins.2009.04.003 Zsido, 2019, Association of estradiol and visceral fat with structural brain networks and memory performance in adults, JAMA Network Open, 2, e196126, 10.1001/jamanetworkopen.2019.6126 Dongfang, 2017, Mechanistic evaluation of neuroprotective effect of estradiol on rotenone and 6-OHDA induced Parkinson's disease, Pharmacol Rep Pr Wenhao, Yan, Jun, Wu, Bo, Song, Qiang, Luo, Yuming, Xu: Treatment with a brain-selective prodrug of 17β-estradiol improves cognitive function in Alzheimer's disease mice by regulating klf5-NF-κB pathway. Naunyn Schmiedebergs Archives of Pharmacology 2019. Filice F, Lauber E, V Rckel KJ, W Hr M, Schwaller B: 17-β estradiol increases parvalbumin levels in Pvalb heterozygous mice and attenuates behavioral phenotypes with relevance to autism core symptoms. Mol Autism 2018, 9(1):15. Thiede, 2012, Complex effects of 17β-estradiol on mitochondrial function, BBA, 1817 Jones, 1986, In situ hybridization detection of estradiol-induced changes in ribosomal RNA levels in rat brain, Mol Brain Res, 1, 145, 10.1016/0169-328X(86)90006-9 Lombardo, 2017, Hierarchical cortical transcriptome disorganization in autism, Mol Autism, 8, 10.1186/s13229-017-0147-7 Griesi-Oliveira, 2020, Transcriptome of iPSC-derived neuronal cells reveals a module of co-expressed genes consistently associated with autism spectrum disorder, Mol Psychiatr, 21, 1 Kaijie, 2018, Histone deacetylase inhibitor MS-275 restores social and synaptic function in a Shank3-deficient mouse model of autism, Neuropsychopharmacology Kilincaslan, 2016, Beneficial effects of everolimus on autism and attention-deficit/hyperactivity disorder symptoms in a group of patients with tuberous sclerosis complex, J Child Adol Psychop, 2016 Mm, 2019, Everolimus for epilepsy and autism spectrum disorder in tuberous sclerosis complex: EXIST-3 substudy in Japan, Brain Dev, 41, 1, 10.1016/j.braindev.2018.07.003 Mcdougle, 1996, A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder, Arch Gen Psychiatry, 53, 1001, 10.1001/archpsyc.1996.01830110037005 Fukuda, 2001, Clinical evaluation of treatment with fluvoxamine, a selective serotonin reuptake inhibitor in children with autistic disorder, No to Hattatsu Brain Dev, 33, 314 Bhandari, 2015, Neuropsychopharmacotherapeutic efficacy of curcumin in experimental paradigm of autism spectrum disorders, Life Sci, 10.1016/j.lfs.2015.09.012 Liu, 2018, The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease, Brain Res Bull, 137, 132, 10.1016/j.brainresbull.2017.11.011 Fontán-Lozano, 2011, The M-current inhibitor XE991 decreases the stimulation threshold for long-term synaptic plasticity in healthy mice and in models of cognitive disease, Hippocampus, 21, 22, 10.1002/hipo.20717 Fortress, 2019, Experimental traumatic brain injury results in estrous cycle disruption, neurobehavioral deficits, and impaired GSK3β/β-catenin signaling in females, Exp Neurol, 315, 42, 10.1016/j.expneurol.2019.01.017 Sanchez-Mejia, 2008, Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease, Nat Neurosci, 11, 1311, 10.1038/nn.2213 Qasem, 2017, Increase of cytosolic phospholipase A2 as hydrolytic enzyme of phospholipids and autism cognitive, social and sensory dysfunction severity, Lipids Health Dis, 16, 117, 10.1186/s12944-016-0391-4